Status:
NOT_YET_RECRUITING
Establishment and Clinical Application of Breast Cancer Risk Prediction Model Based on Traditional Chinese Medicine Four Diagnostic Instruments and Ultrasound
Lead Sponsor:
Taizhou Hospital
Conditions:
Breast Cancer Screening
Eligibility:
FEMALE
30-75 years
Brief Summary
Construct a breast cancer risk prediction model based on traditional Chinese medicine four diagnostic instruments and B-ultrasound images. Ensure that the key evaluation indicators of the model reach ...
Eligibility Criteria
Inclusion
- Female patients aged between 30 and 75.
- Patients who have a mass detected by US examination, need to undergo surgery or needle biopsy, and obtain a definite pathological result.
- Patients who have obtained complete identification results of tongue, pulse, face, and constitution through the traditional Chinese medicine four diagnostic instruments.
Exclusion
- \- 1. Patients with severe heart, liver, or kidney insufficiency, or other serious systemic diseases.
- 2\. Patients with a history of other malignant tumors. 3. Cases with poor - quality B - ultrasound images. 4. Cases with an unclear pathological diagnosis. 5. Patients with obvious lesions on the face, in the oral cavity, or on the tongue that may affect the measurement results.
Key Trial Info
Start Date :
April 26 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 26 2027
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT06902935
Start Date
April 26 2025
End Date
April 26 2027
Last Update
March 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taizhou Central Hospital (Affiliated Hospital of Taizhou University)
Taizhou, Zhejiang, China, 318000